(ANAB) AnaptysBio - Performance -18.3% in 12m
Compare ANAB with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-18.55%
#44 in Group
Rel. Strength
26.75%
#5829 in Universe
Total Return 12m
-18.34%
#64 in Group
Total Return 5y
-1.66%
#39 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -27.53%
(?) Percentile in Group
12m Total Return: ANAB (-18.3%) vs XBI (-14.9%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
7.21% | 14% | 161% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
| HLN NYSE Haleon |
7.98% | 32.4% | 49.3% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
| AMGN NASDAQ Amgen |
-7.04% | -11.2% | 27.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
| LONN SW Lonza |
11.7% | 13.3% | 33.5% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
| BIM PA Biomerieux |
2.2% | 21% | -1.63% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
13.3% | 27.1% | -5.64% | 27.5 | 25.1 | 1 | 32.5% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
27.3% | -15% | 1.88% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
| ERF PA Eurofins Scientific SE |
20% | 0.38% | 8.05% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: ANAB vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ANAB
| Total Return (including Dividends) | ANAB | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 14.09% | 2.77% | 5.69% |
| 3 Months | 58.30% | -14.21% | -6.49% |
| 12 Months | -18.34% | -14.88% | 9.72% |
| 5 Years | -1.66% | -26.47% | 107.51% |
| Trend Score (consistency of price movement) | ANAB | XBI | S&P 500 |
| 1 Month | 40.6% | 57% | 89.4% |
| 3 Months | 60.3% | -82.3% | -72% |
| 12 Months | -66.6% | -53.1% | 49.3% |
| 5 Years | -14.3% | -53.9% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #74 | 11.0% | 7.95% |
| 3 Month | #14 | 84.5% | 69.3% |
| 12 Month | #65 | -4.06% | -25.6% |
| 5 Years | #38 | 33.8% | -52.6% |
FAQs
Does ANAB AnaptysBio outperforms the market?
No,
over the last 12 months ANAB made -18.34%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.88%.
Over the last 3 months ANAB made 58.30%, while XBI made -14.21%.
Over the last 3 months ANAB made 58.30%, while XBI made -14.21%.
Performance Comparison ANAB vs Indeces and Sectors
ANAB vs. Indices ANAB is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -5.65% | 8.40% | -7.39% | -28.1% |
| US NASDAQ 100 | QQQ | -5.92% | 6.70% | -7.80% | -29.1% |
| US Dow Jones Industrial 30 | DIA | -5.54% | 11.4% | -6.36% | -24.6% |
| German DAX 40 | DAX | -6.10% | -0.97% | -33.0% | -43.2% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -5.88% | 11.2% | -6.62% | -24.7% |
| Hongkong Hang Seng | HSI | -8.53% | -0.81% | -16.9% | -26.6% |
| India NIFTY 50 | INDA | -1.95% | 10.9% | -9.29% | -20.4% |
| Brasil Bovespa | EWZ | -8.68% | 2.47% | -16.6% | -12.1% |
ANAB vs. Sectors ANAB is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -5.02% | 7.61% | -13.6% | -38.7% |
| Consumer Discretionary | XLY | -7.07% | 7.40% | -5.20% | -33.2% |
| Consumer Staples | XLP | -4.79% | 13.4% | -14.3% | -25.6% |
| Energy | XLE | -7.90% | 9.60% | -1.39% | -9.32% |
| Financial | XLF | -6.35% | 7.25% | -13.3% | -39.9% |
| Health Care | XLV | -1.55% | 17.2% | -2.16% | -12.3% |
| Industrial | XLI | -6.58% | 5.78% | -8.37% | -28.7% |
| Materials | XLB | -5.81% | 9.05% | -3.34% | -12.3% |
| Real Estate | XLRE | -4.86% | 7.18% | -9.77% | -31.9% |
| Technology | XLK | -6.49% | 4.38% | -5.12% | -24.4% |
| Utilities | XLU | -6.37% | 8.95% | -15.2% | -34.4% |
| Aerospace & Defense | XAR | -5.83% | 4.92% | -16.7% | -44.3% |
| Biotech | XBI | 2.07% | 11.3% | 13.7% | -3.46% |
| Homebuilder | XHB | -5.29% | 8.48% | 6.24% | -9.47% |
| Retail | XRT | -5.71% | 7.95% | -1.10% | -12.1% |